Sanofi ousts CEO Hudson after stalled turnaround at vaccine giant ⊖
found
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Sanofi
since
auto-detected in 6 stories
61 days ago
French drugmaker Sanofi ousted CEO Paul Hudson on Thursday appointed Belén Garijo, the head of German drugmaker Merck KGaA, as new chief executive.
75 days ago
Drugmakers Roche and Sanofi talk up their pipelines, as earnings fail to excite ⊕
The drugmaker's full-year results didn't seem to move the needle for investors who are instead focused on future growth prospects and innovation
3 months ago
Sanofi to acquire hepatitis B vaccine maker Dynavax for $2.2 billion ○
Sanofi will buy U.S. vaccines company Dynavax Technologies for around $2.2 billion (1.9 billion euros), the French drugmaker said on Wednesday.
6 months ago
Brussels raids Sanofi in flu vaccine antitrust probe ⊖
French company is one of three big manufacturers of the vaccines
7 months ago
Britain is ‘a terrible place’ to sell medicines, says drug firm executive ○
found
a story from The Guardian ⚠️ › International
Sanofi’s market access chief urges ministers to come up with a roadmap to raise spending on new treatments
Business live – latest updates
A senior pharmaceuticals executive has called on the government…
10 months ago
FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca ○
Merck's shot will compete against a similar blockbuster treatment from Sanofi and AstraZeneca called Beyfortus.
page 1 of 1